EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases
- MeSH Terms
Autoimmune Diseases of the Nervous System / immunology
Autoimmune Diseases of the Nervous System / therapy
Clinical Trials as Topic
Combined Modality Therapy
Demyelinating Diseases / immunology
Demyelinating Diseases / therapy
Epilepsy / therapy
Evidence-Based Medicine
Humans
Immunoglobulins, Intravenous / administration & dosage
Immunoglobulins, Intravenous / adverse effects
Immunoglobulins, Intravenous / pharmacology
Immunoglobulins, Intravenous / therapeutic use*
Immunosuppressive Agents / therapeutic use
Nervous System Diseases / therapy*
Paraneoplastic Polyneuropathy / immunology
Paraneoplastic Polyneuropathy / therapy
Paraproteinemias / immunology
Paraproteinemias / therapy
Plasma Exchange
- Guideline Contact
- Prof. Irina Elovaara, Department of Neurology and Rehabilitation, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland (tel.: 358 3 311 66692; fax: 358 3 311 64351; e-mail: [email protected])
- Publication Date
- 11 August 2008
- Date of Last Evidence Search
- December 2007
- Methods Applied
- Evidence classification; Experts' recommendations
- Publication Scope
- Humans
- Management
- Management: Treatment
- Treatment
- Management
- Treatment, management
- Countries of Application
- Europe
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- 10
- Willingness to Collaborate
- Yes
